EFFECTS OF D2 DOPAMINE RECEPTOR BLOCKADE WITH RACLOPRIDE ON INTRACRANIAL SELF-STIMULATION AND FOOD-REINFORCED OPERANT-BEHAVIOR

被引:37
作者
NAKAJIMA, S
BAKER, JD
机构
关键词
D O I
10.1007/BF00451683
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:330 / 333
页数:4
相关论文
共 16 条
[1]   STIMULATION OF BOTH D1 AND D2 DOPAMINE-RECEPTORS APPEARS NECESSARY FOR FULL EXPRESSION OF POSTSYNAPTIC EFFECTS OF DOPAMINE AGONISTS - A NEUROPHYSIOLOGICAL STUDY [J].
CARLSON, JH ;
BERGSTROM, DA ;
WALTERS, JR .
BRAIN RESEARCH, 1987, 400 (02) :205-218
[2]   QUANTITATIVE-DETERMINATION OF THE EFFECTS OF CATECHOLAMINERGIC AGONISTS AND ANTAGONISTS ON THE REWARDING EFFICACY OF BRAIN-STIMULATION [J].
GALLISTEL, CR ;
FREYD, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 26 (04) :731-741
[3]   AFFINITY FOR THE DOPAMINE-D2 RECEPTOR PREDICTS NEUROLEPTIC POTENCY IN BLOCKING THE REINFORCING EFFECT OF MFB STIMULATION [J].
GALLISTEL, CR ;
DAVIS, AJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 19 (05) :867-872
[4]   EFFECTS OF RACLOPRIDE ON EXPLORATORY LOCOMOTOR-ACTIVITY, TREADMILL LOCOMOTION, CONDITIONED AVOIDANCE-BEHAVIOR AND CATALEPSY IN RATS - BEHAVIORAL PROFILE COMPARISONS BETWEEN RACLOPRIDE, HALOPERIDOL AND PRECLAMOL [J].
HILLEGAART, V ;
AHLENIUS, S .
PHARMACOLOGY & TOXICOLOGY, 1987, 60 (05) :350-354
[5]   SPECIFIC INVITRO AND INVIVO BINDING OF H-3-RACLOPRIDE - A POTENT SUBSTITUTED BENZAMIDE DRUG WITH HIGH-AFFINITY FOR DOPAMINE D-2 RECEPTORS IN THE RAT-BRAIN [J].
KOHLER, C ;
HALL, H ;
OGREN, SO ;
GAWELL, L .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (13) :2251-2259
[6]   DOPAMINE D-1 RECEPTORS IN THE NUCLEUS ACCUMBENS - INVOLVEMENT IN THE REINFORCING EFFECT OF TEGMENTAL STIMULATION [J].
KURUMIYA, S ;
NAKAJIMA, S .
BRAIN RESEARCH, 1988, 448 (01) :1-6
[7]  
NAKAJIMA S, 1986, PHYSIOL PSYCHOL, V14, P111
[8]   REDUCTION OF THE REWARDING EFFECT OF BRAIN-STIMULATION BY A BLOCKADE OF DOPAMINE D1 RECEPTOR WITH SCH-23390 [J].
NAKAJIMA, S ;
MCKENZIE, GM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (04) :919-923
[9]  
NAKAJIMA S, 1987, SOC NEUR ABSTR
[10]  
OGREN SO, 1986, PSYCHOPHARMACOLOGY, V90, P287